Maxim Integrated Products, Inc. (MXIM)’s SENIOR VP Christopher Neil Unloaded 12,634 Shares of the Company; Fuller & Thaler Asset Management Boosted By $1.70 Million Its Corcept Therapeutics (CORT) Holding

Fuller & Thaler Asset Management Inc increased Corcept Therapeutics Inc (CORT) stake by 161.91% reported in 2017Q3 SEC filing. Fuller & Thaler Asset Management Inc acquired 89,700 shares as Corcept Therapeutics Inc (CORT)’s stock rose 42.01%. The Fuller & Thaler Asset Management Inc holds 145,100 shares with $2.80 million value, up from 55,400 last quarter. Corcept Therapeutics Inc now has $2.65 billion valuation. The stock decreased 1.98% or $0.47 during the last trading session, reaching $23.21. About 797,196 shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 124.81% since January 31, 2017 and is uptrending. It has outperformed by 108.11% the S&P500.

SENIOR VP Christopher Neil of Maxim Integrated Products Inc, unloaded some 12,634 of the public company shares worth near $783,466 U.S Dollars with an average of $62.0 stock price per share. In the last month, he also unloaded 3,500 shares with a total value of about $183,950 USD. Christopher Neil now owns 127,291 shares or 0.06% of the company’s market capitalization. A document free at your disposal for review here revealed this transaction activity. It was revealed on January 31, 2018 and filled with SEC.

Among 4 analysts covering Corcept Therapeutics (NASDAQ:CORT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Corcept Therapeutics had 7 analyst reports since February 2, 2017 according to SRatingsIntel. As per Friday, November 3, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Piper Jaffray with “Buy” on Thursday, August 24. Piper Jaffray maintained Corcept Therapeutics Incorporated (NASDAQ:CORT) rating on Friday, September 8. Piper Jaffray has “Buy” rating and $24.0 target. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, October 11. Ladenburg Thalmann initiated the stock with “Buy” rating in Thursday, February 2 report.

Fuller & Thaler Asset Management Inc decreased Stamps.Com (NASDAQ:STMP) stake by 9,985 shares to 106,435 valued at $21.57 million in 2017Q3. It also reduced Priceline Group Inc/The (NASDAQ:PCLN) stake by 475 shares and now owns 3,088 shares. Alpha And Omega Semiconductr (NASDAQ:AOSL) was reduced too.

Since December 8, 2017, it had 0 insider purchases, and 2 insider sales for $283,125 activity. FISHMAN ROBERT S sold 8,000 shares worth $149,349.

Investors sentiment decreased to 1.96 in Q3 2017. Its down 0.47, from 2.43 in 2017Q2. It is negative, as 13 investors sold CORT shares while 39 reduced holdings. 47 funds opened positions while 55 raised stakes. 71.96 million shares or 6.38% more from 67.64 million shares in 2017Q2 were reported. Zebra Mgmt Limited Co holds 0.21% or 33,891 shares. Macquarie Group Inc Ltd stated it has 7,100 shares or 0% of all its holdings. Citadel Advsrs Ltd Co reported 131,836 shares stake. Utd Svcs Automobile Association owns 48,980 shares. 10,300 were accumulated by Caxton Associate Limited Partnership. Ameriprise Fin Inc holds 301,695 shares. Amalgamated Bancorp owns 0.01% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 11,579 shares. Virginia Retirement Et Al holds 108,500 shares. The New York-based Laurion Cap Management Lp has invested 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Cornerstone Cap Mngmt Holdg Ltd Company owns 105,000 shares for 0.02% of their portfolio. Moreover, Timpani Capital Management Ltd Co has 1.22% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 173,711 shares. Sta Wealth Mngmt Limited Company, Texas-based fund reported 34,849 shares. Jacobs Levy Equity Management owns 19,810 shares for 0.01% of their portfolio. Shaker Lc Oh invested in 114,085 shares or 1.53% of the stock. Moreover, Acadian Asset Management Ltd Limited Liability Company has 0.2% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 2.30M shares.

Since August 1, 2017, it had 0 insider buys, and 19 sales for $10.93 million activity. $1.11M worth of Maxim Integrated Products, Inc. (NASDAQ:MXIM) was sold by DOLUCA TUNC. 25,000 shares valued at $1.13M were sold by KIDDOO BRUCE E on Monday, August 14. Wright Mary Ann had sold 560 shares worth $25,922 on Monday, September 11. 3,500 shares were sold by NEIL CHRISTOPHER J, worth $166,243. 6,793 shares were sold by Jain Vivek, worth $354,459. Another trade for 1,234 shares valued at $56,412 was sold by Preeshl Bryan. 30,849 Maxim Integrated Products, Inc. (NASDAQ:MXIM) shares with value of $1.39 million were sold by Grady Robert Edward.

Maxim Integrated Products, Inc. designs, develops, makes, and markets a range of linear and mixed-signal integrated circuits in the United States, China, rest of Asia, Europe, and internationally. The company has market cap of $13.37 billion. The firm also provides a range of high-frequency process technologies and capabilities for use in custom designs. It has a 45.99 P/E ratio. It serves automotive, communications and data center, computing, consumer, and industrial markets.

The stock decreased 0.73% or $0.45 during the last trading session, reaching $61.26. About 3.18 million shares traded or 44.04% up from the average. Maxim Integrated Products, Inc. (NASDAQ:MXIM) has risen 31.27% since January 31, 2017 and is uptrending. It has outperformed by 14.57% the S&P500.

Among 30 analysts covering Maxim Integrated Products Inc. (NASDAQ:MXIM), 15 have Buy rating, 1 Sell and 14 Hold. Therefore 50% are positive. Maxim Integrated Products Inc. has $73 highest and $31 lowest target. $51.58’s average target is -15.80% below currents $61.26 stock price. Maxim Integrated Products Inc. had 85 analyst reports since July 24, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained Maxim Integrated Products, Inc. (NASDAQ:MXIM) on Friday, January 26 with “Buy” rating. Citigroup maintained the stock with “Neutral” rating in Monday, October 23 report. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, January 18 report. Drexel Hamilton maintained Maxim Integrated Products, Inc. (NASDAQ:MXIM) on Friday, October 20 with “Buy” rating. The stock of Maxim Integrated Products, Inc. (NASDAQ:MXIM) has “Equal-Weight” rating given on Wednesday, August 31 by Barclays Capital. As per Thursday, May 25, the company rating was maintained by Stifel Nicolaus. Oppenheimer maintained Maxim Integrated Products, Inc. (NASDAQ:MXIM) on Tuesday, June 13 with “Hold” rating. BMO Capital Markets downgraded the stock to “Market Perform” rating in Tuesday, July 19 report. The firm has “Market Perform” rating by BMO Capital Markets given on Friday, October 20. The stock has “Outperform” rating by RBC Capital Markets on Friday, April 8.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: